Activation of Nrf2 Signaling Augments Vesicular Stomatitis Virus Oncolysis via Autophagy-Driven Suppression of Antiviral Immunity
- PMID: 28527723
- PMCID: PMC5542709
- DOI: 10.1016/j.ymthe.2017.04.022
Activation of Nrf2 Signaling Augments Vesicular Stomatitis Virus Oncolysis via Autophagy-Driven Suppression of Antiviral Immunity
Abstract
Oncolytic viruses (OVs) offer a promising therapeutic approach to treat multiple types of cancer. In this study, we show that the manipulation of the antioxidant network via transcription factor Nrf2 augments vesicular stomatitis virus Δ51 (VSVΔ51) replication and sensitizes cancer cells to viral oncolysis. Activation of Nrf2 signaling by the antioxidant compound sulforaphane (SFN) leads to enhanced VSVΔ51 spread in OV-resistant cancer cells and improves the therapeutic outcome in different murine syngeneic and xenograft tumor models. Chemoresistant A549 lung cancer cells that display constitutive dominant hyperactivation of Nrf2 signaling are particularly vulnerable to VSVΔ51 oncolysis. Mechanistically, enhanced Nrf2 signaling stimulated viral replication in cancer cells and disrupted the type I IFN response via increased autophagy. This study reveals a previously unappreciated role for Nrf2 in the regulation of autophagy and the innate antiviral response that complements the therapeutic potential of VSV-directed oncolysis against multiple types of OV-resistant or chemoresistant cancer.
Keywords: Nrf2; VSV; autophagy; cancer; innate antiviral response; interferon; oncolysis.
Copyright © 2017 The Author(s). Published by Elsevier Inc. All rights reserved.
Figures








Similar articles
-
Triptolide-mediated inhibition of interferon signaling enhances vesicular stomatitis virus-based oncolysis.Mol Ther. 2013 Nov;21(11):2043-53. doi: 10.1038/mt.2013.187. Epub 2013 Aug 28. Mol Ther. 2013. PMID: 23985699 Free PMC article.
-
Histone deacetylase inhibitors potentiate vesicular stomatitis virus oncolysis in prostate cancer cells by modulating NF-κB-dependent autophagy.J Virol. 2014 Mar;88(5):2927-40. doi: 10.1128/JVI.03406-13. Epub 2013 Dec 26. J Virol. 2014. PMID: 24371063 Free PMC article.
-
Resistance of pancreatic cancer cells to oncolytic vesicular stomatitis virus: role of type I interferon signaling.Virology. 2013 Feb 5;436(1):221-34. doi: 10.1016/j.virol.2012.11.014. Epub 2012 Dec 14. Virology. 2013. PMID: 23246628 Free PMC article.
-
Employing the Oncolytic Vesicular Stomatitis Virus in Cancer Virotherapy: Resistance and Clinical Considerations.Viruses. 2024 Dec 25;17(1):16. doi: 10.3390/v17010016. Viruses. 2024. PMID: 39861805 Free PMC article. Review.
-
Potential of vesicular stomatitis virus as an oncolytic therapy for recurrent and drug-resistant ovarian cancer.Chin J Cancer. 2011 Dec;30(12):805-14. doi: 10.5732/cjc.011.10205. Epub 2011 Nov 4. Chin J Cancer. 2011. PMID: 22059911 Free PMC article. Review.
Cited by
-
A novel marine-derived anti-acute kidney injury agent targeting peroxiredoxin 1 and its nanodelivery strategy based on ADME optimization.Acta Pharm Sin B. 2024 Jul;14(7):3232-3250. doi: 10.1016/j.apsb.2024.03.005. Epub 2024 Mar 8. Acta Pharm Sin B. 2024. PMID: 39027260 Free PMC article.
-
Transcription factors NRF2 and HSF1 have opposing functions in autophagy.Sci Rep. 2017 Sep 8;7(1):11023. doi: 10.1038/s41598-017-11262-5. Sci Rep. 2017. PMID: 28887499 Free PMC article.
-
The gamble between oncolytic virus therapy and IFN.Front Immunol. 2022 Aug 25;13:971674. doi: 10.3389/fimmu.2022.971674. eCollection 2022. Front Immunol. 2022. PMID: 36090998 Free PMC article. Review.
-
Glucose metabolite methylglyoxal induces vascular endothelial cell pyroptosis via NLRP3 inflammasome activation and oxidative stress in vitro and in vivo.Cell Mol Life Sci. 2024 Sep 13;81(1):401. doi: 10.1007/s00018-024-05432-8. Cell Mol Life Sci. 2024. PMID: 39269632 Free PMC article.
-
Nrf2 antioxidant pathway suppresses Numb-mediated epithelial-mesenchymal transition during pulmonary fibrosis.Cell Death Dis. 2018 Jan 23;9(2):83. doi: 10.1038/s41419-017-0198-x. Cell Death Dis. 2018. PMID: 29362432 Free PMC article.
References
-
- Lichty B.D., Breitbach C.J., Stojdl D.F., Bell J.C. Going viral with cancer immunotherapy. Nat. Rev. Cancer. 2014;14:559–567. - PubMed
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
Miscellaneous